Details for Patent: 9,693,989
✉ Email this page to a colleague
Which drugs does patent 9,693,989 protect, and when does it expire?
Patent 9,693,989 protects TUKYSA and is included in one NDA.
This patent has fifty-three patent family members in twenty-nine countries.
Summary for Patent: 9,693,989
| Title: | N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
| Abstract: | This invention provides compounds of Formula I ##STR00001## wherein B, G, A, E, R.sup.1, R.sup.2, R.sup.3, m and n are as defined herein, which are useful as type I receptor tyrosine kinase inhibitors, and methods of use thereof in the treatment of hyperproliferative disorders in mammals. |
| Inventor(s): | Lyssikatos; Joseph P. (Piedmont, CA), Hicks; Julie Marie (Erie, CO), Marmsater; Fredrik P. (Boulder, CO), Zhao; Qian (Superior, CO) |
| Assignee: | Array Biopharma, Inc. (Boulder, CO) |
| Application Number: | 14/034,361 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Compound; |
Drugs Protected by US Patent 9,693,989
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Seagen | TUKYSA | tucatinib | TABLET;ORAL | 213411-001 | Apr 17, 2020 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF BREAST CANCER INCLUDING HER2 (ERBB2)-POSITIVE OR -OVEREXPRESSING BREAST CANCER | ⤷ Sign Up | |||
| Seagen | TUKYSA | tucatinib | TABLET;ORAL | 213411-002 | Apr 17, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF BREAST CANCER INCLUDING HER2 (ERBB2)-POSITIVE OR -OVEREXPRESSING BREAST CANCER | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,693,989
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1971601 | ⤷ Sign Up | C01971601/01 | Switzerland | ⤷ Sign Up |
| European Patent Office | 1971601 | ⤷ Sign Up | 301113 | Netherlands | ⤷ Sign Up |
| European Patent Office | 1971601 | ⤷ Sign Up | CA 2021 00025 | Denmark | ⤷ Sign Up |
| European Patent Office | 1971601 | ⤷ Sign Up | LUC00217 | Luxembourg | ⤷ Sign Up |
| European Patent Office | 1971601 | ⤷ Sign Up | PA2021516 | Lithuania | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
